Catalog2 refs
Crystagen
BioregulatorsImmune ModulationResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
Overview
Crystagen is a Khavinson bioregulator tripeptide (EDP) identified in thymalin with selective action on thymus tissues. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology, it enhances immune function by stimulating normal lymphocyte proliferation while inhibiting tumor cell growth. Research shows effectiveness in normalizing immunity in 82% of elderly patients (vs 56% control) and reducing respiratory infections in athletes by doubling HSP gene expression.
Primary Uses
Immune function support
T-cell and cytokine research
Immunosenescence models
Adjunct recovery protocols
Immune dysfunction normalization in elderly patients
Post-infection immune recovery
Radiation and chemotherapy immune recovery
Athletic immune support and stress resistance
HSP gene expression enhancement
Tumor cell proliferation inhibition
B-cell immune system activation
IL-6 expression normalization
Immune system regulation
Thymic regulation
T-cell function restoration in aged immune cells
Chromatin reactivation in aged cells
Lymphocyte proliferation and differentiation
Protocol Reference
Dose
20-40mg
Frequency
1-2 times daily with food
Half-life
Not Well Characterized
Route
Oral
Evidence
Preclinical / Moderate Research (disputed)
Research References· 2
https://pubmed.ncbi.nlm.nih.gov/15085253/
PubMedPMID 15085253- [https://pmc.ncbi.nlm.nih.gov/articles/PMC8619776/](https://pmc.ncbi.nlm.nih.gov/articles/PMC8619776/)
Research Models
Human
Also in Bioregulators